Newsletter | May 8, 2019

05.08.19 -- An Introduction To Centerlining For Biopharma Manufacturing

Featured Editorial
An Introduction To Centerlining For Biopharmaceutical Manufacturing
By Tobias Kuners of Koenders

Many biopharma companies struggle to strike the right balance between enough preventative maintenance and not too much corrective maintenance for manufacturing equipment, and to achieve that balance at a reasonable cost. One method known to drive the preventative/corrective ratio in favor of preventative maintenance is centerlining.

Risk Assessment Of Objectionable Microorganisms In Nonsterile Pharmaceuticals
By Crystal M. Booth, PSC Biotech

This is Part 2 of a two-part article on objectionable microorganisms in the nonsterile microbiology industry. It discusses a risk-based approach to determine if a microorganism is objectionable for an application.

Industry Insights
The Advantages Of A Cross-Functional Staff Model In Pharmaceutical Manufacturing
Article | By Tommy Bowlen, Singota Solutions

An individual that knows the product and processes from start to finish, having performed the tasks at each stage, gives the client reassurance and the CMO retains a valuable employee by avoiding burnout or loss of focus.

Introduction To Chromatography For Protein Purification
Article | By Mark Snyder, Ph.D., Bio-Rad Laboratories, Inc.

Whether these proteins are produced by recombinant DNA technology or extracted from sources such as plasma, they need to be highly purified — and the purification process must satisfy a variety of regulations.

The Pharma Trends You Need To Know: A CDMO’s Perspective
Article | By Anil Kane, Ph.D., MBA , Thermo Fisher Scientific

Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.

Critical Considerations About The Future Of Global Cell Culture Bioprocessing
White Paper | By Günter Jagschies, GE Healthcare Life Sciences

In today’s changing industry, it is critical we consider several factors about cell culture bioprocessing and the impact they will have on the future of patient treatment.

Tackling The Challenges Of Biologics Development And Manufacturing
Article | AbbVie

Biologics offer distinct advantages that small molecule drugs do not, but they are far more complex to develop and manufacture. Read why it is critical to have the right manufacturing partner to minimize challenges as a therapy moves from discovery to commercialization.

Finding The Equivalent Performance Of Individual And Stacked Cassettes
Application Note | JSR Life Sciences

The stacking ability of matched Chromassette devices enables easy and quick adjustment of resin volumes in order to meet the capacity requirements of individual processes.


BioProcess International is the largest bioprocessing event bringing you the science, technologies, and partners needed to accelerate promising biologics toward commercial success. Register today to join 2,000+ bioprocessing scientists and engineers at this year’s meeting, held September 9 to 12, 2019, in Boston.

Provantage End-To-End Services
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With BioProcess Online: